Clinical Trials Browser

INDUSTRY × Interventional × nabiximols × Clear all

NCT00674609 2023-05-03

SPRAY

Phase 3 Completed

177 enrolled 21 charts

Neoplasms, Pain

NCT00675948 2023-05-03

Study to Compare the Safety and Tolerability of Sativex® in Patients With Cancer Related Pain

Phase 3 Completed

43 enrolled 11 charts

Neoplasms, Pain

NCT01337089 2023-04-12

Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

Phase 3 Completed

660 enrolled 9 charts

Cancer Pain, Pain

NCT01361607 2023-04-12

SPRAY III

Phase 3 Completed

399 enrolled 17 charts

Cancer Pain, Pain

NCT01424566 2023-04-12

A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer

Phase 3 Completed

406 enrolled 16 charts

Cancer Pain, Pain

NCT01812603 2022-12-20

A Safety Study of Sativex in Combination With Dose-intense Temozolomide in Patients With Recurrent Glioblastoma

Phase 1/2 Completed

Neoplasms

NCT01812616 2022-12-20

A Safety Study of Sativex Compared With Placebo (Both With Dose-intense Temozolomide) in Recurrent Glioblastoma Patients

Phase 1/2 Completed

Neoplasms

NCT03522467 2019-09-25

COPE

Phase 2 Unknown

Marijuana Abuse, Neoplasms, Pain, Chronic Pain